论文部分内容阅读
目的:分析小儿呼吸道感染患儿采用阿奇霉素治疗的安全性和有效性。方法:选取张家港市中医医院2015年5月至2016年5月收治的86例小儿呼吸道感染患儿,运用随机数字表法分为观察组和对照组各43例,对照组患儿给予阿莫西林克拉维酸钾治疗,观察组患者采用阿奇霉素治疗,通过临床症状缓解时间、治疗有效率、不良反应发生率等指标判断临床治疗效果。结果:观察组患儿咳嗽、流涕、发热、肺部啰音缓解或消失时间、住院时间较对照组明显缩短;治疗总有效率97.67%明显高于对照组的86.05%,不良反应发生率4.65%明显低于对照组的13.95%,组间比较,差异具有统计学意义(P<0.05)。结论:针对呼吸道感染患儿,采用阿奇霉素治疗,有利于缓解临床症状,提高治疗有效率,减少不良反应,安全可靠。
Objective: To analyze the safety and efficacy of azithromycin in children with respiratory tract infection. Methods: Totally 86 children with respiratory tract infection were selected from Zhangjiagang Hospital of Traditional Chinese Medicine from May 2015 to May 2016. The patients were randomly divided into observation group (43 cases) and control group (43 cases). The control group was given amoxicillin Clavulanate potassium treatment, the observation group patients with azithromycin treatment, clinical symptoms and signs through the clinical symptoms of remission time, treatment efficiency, adverse reactions and other indicators to determine the clinical effect. Results: The cough, runny nose, fever and the amelioration or disappearance of pulmonary rales in the observation group were significantly shorter than those in the control group. The total effective rate was 97.67% in the observation group and 86.05% in the control group, and the incidence of adverse reactions was 4.65 % Was significantly lower than that of the control group (13.95%). There was significant difference between the two groups (P <0.05). Conclusion: For children with respiratory tract infection, azithromycin treatment is beneficial to relieve clinical symptoms, improve treatment efficiency, reduce adverse reactions, and be safe and reliable.